Advertisement

Intensive Care Medicine

, Volume 45, Issue 2, pp 211–222 | Cite as

A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients

  • Henry T. StelfoxEmail author
  • Rebecca Brundin-Mather
  • Andrea Soo
  • Jeanna Parsons Leigh
  • Daniel J. Niven
  • Kirsten M. Fiest
  • Christopher James Doig
  • Danny J. Zuege
  • Barry Kushner
  • Fiona Clement
  • Sharon E. Straus
  • Deborah J. Cook
  • Sean M. Bagshaw
  • Khara M. Sauro
Original

Abstract

Purpose

To test whether a multicomponent intervention would increase the use of low molecular weight heparin (LMWH) over unfractionated heparin (UFH) for venous thromboembolism (VTE) prophylaxis in critically ill patients and change patient outcomes and healthcare utilization.

Methods

Controlled pre–post trial of 12,342 adults admitted to 11 ICUs (five intervention, six control) May 1, 2015 to April 30, 2017 with no contraindication to pharmacological prophylaxis and an ICU stay longer than 24 h. Models were developed to examine temporal changes in ICU VTE prophylaxis (primary outcome), VTE, major bleeding, heparin-induced thrombocytopenia (HIT), death and hospital costs.

Results

The use of LMWH increased from 45.9% to 78.3% of patient days in the intervention group and from 37.9% to 53.3% in the control group, an absolute increase difference of 17.0% (32.4% vs. 15.4%, p = 0.001). Changes in the administration of UFH were inversely related to those of LMWH. There were no significant differences in the adjusted odds of VTE (ratio of odds ratios [rOR] 1.13, 95% CI 0.51–2.46) or major bleeding (rOR 1.22, 95% CI 0.97–1.54) post-implementation of the intervention (compared to pre-implementation) between the intervention group and the control group. HIT was uncommon in both groups (n = 20 patients). There were no significant changes for ICU and hospital mortality, length of stay and costs. Results were similar when stratified according to reason for ICU admission, patient weight and kidney function.

Conclusions

A multicomponent intervention changed practice, but not clinical and economic outcomes. The benefit of implementing LMWH for VTE prophylaxis under real-world conditions is uncertain.

Keywords

Intensive care units Critical care Venous thromboembolism Heparin Implementation science Effectiveness 

Notes

Acknowledgements

The study was funded by a PRIHS Alberta Innovates—Health Solutions (20100368). HTS was supported by a Population Health Investigator Award from Alberta Innovates—Health Solutions and an Embedded Clinician Researcher Award from the Canadian Institutes of Health Research. SMB was supported by a Canada Research Chair in Critical Care Nephrology and Clinical Investigator Award from Alberta Innovates—Health Solutions. Funding sources had no role in the design, conduct, or reporting of this study and we are unaware of any conflicts of interest. Drs Stelfox and Soo had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Compliance with ethical standards

Conflicts of interest

Funding sources had no role in the design, conduct, or reporting of this study and we are unaware of any conflicts of interest.

Ethical approval

The health research ethics boards at the University of Calgary (16-0541) and University of Alberta (Pro000065343) approved this study.

Supplementary material

134_2019_5532_MOESM1_ESM.docx (171 kb)
Supplementary material 1 (DOCX 172 kb)
134_2019_5532_MOESM2_ESM.docx (79 kb)
Supplementary material 2 (DOCX 79 kb)

References

  1. 1.
    Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH (2001) Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 161:1268–1279Google Scholar
  2. 2.
    Protect Investigators for the Canadian Critical Care Trials Group and ANZICSCT Group, Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, Zytaruk N, Crowther M, Geerts W, Cooper DJ, Vallance S, Qushmaq I, Rocha M, Berwanger O, Vlahakis NE (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med. 364:1305–1314Google Scholar
  3. 3.
    Fowler RA, Mittmann N, Geerts WH, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D, Canadian Critical Care Trials Group, Australia and New Zealand Intensive Care Society Clinical Trials Group (2014) Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial. Trials 15:502Google Scholar
  4. 4.
    Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:2088–2098Google Scholar
  5. 5.
    Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377Google Scholar
  6. 6.
    Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45:486–552Google Scholar
  7. 7.
    Sauro KM, Bagshaw M, Niven D, Soo A, Brundin-Mather R, Parsons Leigh J, Cook D, Stelfox D (2019) Barriers and facilitators to adopting high value and de-adopting low value practices in the intensive care unit. BMJ Open.  https://doi.org/10.1136/bmjopen-2018-024159 Google Scholar
  8. 8.
    Cook D, Duffett M, Lauzier F, Ye C, Dodek P, Paunovic B, Fowler R, Kho ME, Foster D, Stelfox T, Sinuff T, Zytaruk N, Clarke F, Wood G, Cox M, Kutsiogiannis J, Jacka M, Roussos M, Kumar H, Guyatt G, CONECCKT-T (Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis) Investigators, Canadian Critical Care Trials Group (2014) Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter survey. J Crit Care 29(471):e471–e479Google Scholar
  9. 9.
    Lauzier F, Muscedere J, Deland E, Kutsogiannis DJ, Jacka M, Heels-Ansdell D, Crowther M, Cartin-Ceba R, Cox MJ, Zytaruk N, Foster D, Sinuff T, Clarke F, Thompson P, Hanna S, Cook D, Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis Investigators, Canadian Critical Care Trials Group (2014) Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit. Crit Care 18:R82Google Scholar
  10. 10.
    Garcia-Olivares P, Guerrero JE, Galdos P, Carriedo D, Murillo F, Rivera A (2014) PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain. Intensive Care Med 40:1698–1708Google Scholar
  11. 11.
    Committee on Quality Health Care in America, Institute of Medicine (2001) Crossing the quality chasm: a new health system for the 21st century. National Academy Press, WashingtonGoogle Scholar
  12. 12.
    Niven DJ, Rubenfeld GD, Kramer AA, Stelfox HT (2015) Effect of published scientific evidence on glycemic control in adult intensive care units. JAMA Intern Med 175:801–809Google Scholar
  13. 13.
    Sinuff T, Muscedere J, Adhikari NK, Stelfox HT, Dodek P, Heyland DK, Rubenfeld GD, Cook DJ, Pinto R, Manoharan V, Currie J, Cahill N, Friedrich JO, Amaral A, Piquette D, Scales DC, Dhanani S, Garland A, Kritical Working Group, Canadian Critical Care Trials Group, Canadian Critical Care Society (2013) Knowledge translation interventions for critically ill patients: a systematic review. Crit Care Med 41:2627–2640Google Scholar
  14. 14.
    Niven DJ, McCormick TJ, Straus SE, Hemmelgarn BR, Jeffs L, Barnes TRM, Stelfox HT (2018) Reproducibility of clinical research in critical care: a scoping review. BMC Med 16:26Google Scholar
  15. 15.
    Weiss CH, Krishnan JA, Au DH, Bender BG, Carson SS, Cattamanchi A, Cloutier MM, Cooke CR, Erickson K, George M, Gerald JK, Gerald LB, Goss CH, Gould MK, Hyzy R, Kahn JM, Mittman BS, Moseson EM, Mularski RA, Parthasarathy S, Patel SR, Rand CS, Redeker NS, Reiss TF, Riekert KA, Rubenfeld GD, Tate JA, Wilson KC, Thomson CC, ATS Ad Hoc Committee on Implementation Science (2016) An official American Thoracic Society research statement: implementation science in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med 194:1015–1025Google Scholar
  16. 16.
    Halpern SD, Becker D, Curtis JR, Fowler R, Hyzy R, Kaplan LJ, Rawat N, Sessler CN, Wunsch H, Kahn JM, Choosing Wisely Taskforce, American Thoracic Society, American Association of Critical-Care Nurses, Society of Critical Care Medicine (2014) An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine policy statement: the choosing Wisely® top 5 list in critical care medicine. Am J Respir Crit Care Med 190:818–826Google Scholar
  17. 17.
    Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP, Stelfox HT (2015) Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med 13:255Google Scholar
  18. 18.
    Des Jarlais DC, Lyles C, Crepaz N, TREND Group (2004) Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 94:361–366Google Scholar
  19. 19.
    Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, Rycroft-Malone J, Meissner P, Murray E, Patel A, Sheikh A, Taylor SJ, StaRI Group (2017) Standards for reporting implementation studies (StaRI) statement. BMJ 356:i6795Google Scholar
  20. 20.
    Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan AW, Michie S (2014) Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 348:g1687Google Scholar
  21. 21.
    French SD, Green SE, O’Connor DA, McKenzie JE, Francis JJ, Michie S, Buchbinder R, Schattner P, Spike N, Grimshaw JM (2012) Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implement Sci 7:38Google Scholar
  22. 22.
    Medical Research Council (2000) A framework for the development and evaluation of RCTs for complex interventions to improve health. MRC, LondonGoogle Scholar
  23. 23.
    Sauro KM, Brundin-Mather R, Parsons Leigh J, Niven DJ, Kushner B, Soo A, Cook DJ, Straus S, Doig CJ, Bagshaw S, Stelfox HT (2018) Improving the adoption of optimal venous thromboembolism prophylaxis in critically ill patients: a process evaluation of a complex quality improvement initiative. J Crit Care 50:111–117Google Scholar
  24. 24.
    Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27:299–309Google Scholar
  25. 25.
    Nyquist P, Bautista C, Jichici D, Burns J, Chhangani S, DeFilippis M, Goldenberg FD, Kim K, Liu-DeRyke X, Mack W, Meyer K (2016) Prophylaxis of venous thrombosis in neurocritical care patients: an evidence-based guideline: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care 24:47–60Google Scholar
  26. 26.
    Toker S, Hak DJ, Morgan SJ (2011) Deep vein thrombosis prophylaxis in trauma patients. Thrombosis 2011:505373Google Scholar
  27. 27.
    Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, Yale SH, Go AS (2017) Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: the CVRN VTE study. Med Care 55:e137–e143Google Scholar
  28. 28.
    Sauro KM, Soo A, Kramer A, Couillard P, Kromm J, Zygun D, Niven DJ, Bagshaw SM, Stelfox HT (2018) Venous thromboembolism prophylaxis in neurocritical care patients: are current practices, best practices? Neurocrit Care.  https://doi.org/10.1007/s12028-018-0614-9 Google Scholar
  29. 29.
    Kaatz S, Ahmad D, Spyropoulos AC, Schulman S, Subcommittee on Control of Anticoagulation (2015) Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13:2119–2126Google Scholar
  30. 30.
    Chiasson TC, Manns BJ, Stelfox HT (2009) An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med 6:e1000098Google Scholar
  31. 31.
    Drummond M, Sculpher M, Torrance G (2005) Cost analysis. Methods for the economic evaluation of health care programmes. Oxford University Press, OxfordGoogle Scholar
  32. 32.
    Agency for Healthcare Research and Quality (2014) Registries for evaluating patient outcomes: a user’s guide. Agency for Healthcare Research and Quality, RockvilleGoogle Scholar
  33. 33.
    Stelfox HT, Soo A, Niven DJ, Fiest KM, Wunsch H, Rowan KM, Bagshaw SM (2018) Assessment of the safety of discharging select patients directly home from the intensive care unit: a multicenter population-based cohort study. JAMA Intern Med 178:1390–1399Google Scholar
  34. 34.
    Brundin-Mather R, Soo A, Zuege DJ, Niven DJ, Fiest K, Doig CJ, Zygun D, Boyd JM, Parsons Leigh J, Bagshaw SM, Stelfox HT (2018) Secondary EMR data for quality improvement and research: a comparison of manual and electronic data collection from an integrated critical care electronic medical record system. J Crit Care 47:295–301Google Scholar
  35. 35.
    Mancl LA, DeRouen TA (2001) A covariance estimator for GEE with improved small-sample properties. Biometrics 57:126–134Google Scholar
  36. 36.
    Wang M (2015) geesmv: Modified Variance Estimators for Generalized Estimating Equations. R package version 1.3. https://CRAN.R-project.org/package=geesmv
  37. 37.
    Stelfox HT, Bastos J, Niven DJ, Bagshaw SM, Turin TC, Gao S (2016) Critical care transition programs and the risk of readmission or death after discharge from ICU. Intensive Care Med 42:401–410Google Scholar
  38. 38.
    R Core Team (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, ViennaGoogle Scholar
  39. 39.
    Højsgaard S, Halekoh U, Yan J (2006) The R package geepack for generalized estimating equations. J Stat Softw 15:1–11Google Scholar
  40. 40.
    Stelfox HT, Niven DJ, Clement FM, Bagshaw SM, Cook DJ, McKenzie E, Potestio ML, Doig CJ, O’Neill B, Zygun D, Critical Care Strategic Clinical Network, Alberta Health Services (2015) Stakeholder engagement to identify priorities for improving the quality and value of critical care. PLoS One 10:e0140141Google Scholar
  41. 41.
    Gill M, Bagshaw SM, McKenzie E, Oxland P, Oswell D, Boulton D, Niven DJ, Potestio ML, Shklarov S, Marlett N, Stelfox HT, Critical Care Strategic Clinical Network (2016) Patient and family member-led research in the intensive care unit: a novel approach to patient-centered research. PLoS One 11:e0160947Google Scholar
  42. 42.
    McKenzie E, Potestio ML, Boyd JM, Niven DJ, Brundin-Mather R, Bagshaw SM, Stelfox HT, Improving Daily Care in the ICU Panel (2017) Reconciling patient and provider priorities for improving the care of critically ill patients: a consensus method and qualitative analysis of decision making. Health Expect 20:1367–1374Google Scholar
  43. 43.
    Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e195S–e226SGoogle Scholar
  44. 44.
    Kahn SR, Morrison DR, Diendere G, Piche A, Filion KB, Klil-Drori AJ, Douketis JD, Emed J, Roussin A, Tagalakis V, Morris M, Geerts W (2018) Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database Syst Rev 4:CD008201Google Scholar
  45. 45.
    Writing Group for the C-ICUI, the Brazilian Research in Intensive Care Network, Cavalcanti AB, Bozza FA, Machado FR, Salluh JI, Campagnucci VP, Vendramim P, Guimaraes HP, Normilio-Silva K, Damiani LP, Romano E, Carrara F, Lubarino Diniz de Souza J, Silva AR, Ramos GV, Teixeira C, Brandao da Silva N, Chang CC, Angus DC, Berwanger O (2016) Effect of a quality improvement intervention with daily round checklists, goal setting, and clinician prompting on mortality of critically ill patients: a randomized clinical trial. JAMA 315:1480–1490Google Scholar
  46. 46.
    Pagoto SL, Lemon SC (2013) Efficacy vs effectiveness. JAMA Intern Med 173:1262–1263Google Scholar
  47. 47.
    Buchman TG, Azoulay E (2017) Practice guidelines as implementation science: the journal editors’ perspective. Intensive Care Med 43:378–379Google Scholar
  48. 48.
    Buchman TG, Azoulay E (2017) Practice guidelines as implementation science: the journal editors’ perspective. Crit Care Med 45:553–554Google Scholar
  49. 49.
    Fretheim A, Soumerai SB, Zhang F, Oxman AD, Ross-Degnan D (2013) Interrupted time-series analysis yielded an effect estimate concordant with the cluster-randomized controlled trial result. J Clin Epidemiol 66:883–887Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Henry T. Stelfox
    • 1
    • 2
    • 3
    Email author
  • Rebecca Brundin-Mather
    • 4
  • Andrea Soo
    • 1
    • 3
  • Jeanna Parsons Leigh
    • 1
    • 2
  • Daniel J. Niven
    • 1
    • 2
  • Kirsten M. Fiest
    • 1
    • 2
  • Christopher James Doig
    • 1
    • 2
    • 3
  • Danny J. Zuege
    • 1
    • 3
  • Barry Kushner
    • 1
    • 3
  • Fiona Clement
    • 2
  • Sharon E. Straus
    • 5
  • Deborah J. Cook
    • 6
  • Sean M. Bagshaw
    • 7
  • Khara M. Sauro
    • 1
    • 2
  1. 1.Department of Critical Care MedicineUniversity of CalgaryCalgaryCanada
  2. 2.Department of Community Health SciencesUniversity of CalgaryCalgaryCanada
  3. 3.Alberta Health ServicesCalgaryCanada
  4. 4.W21C Research and Innovation CentreUniversity of CalgaryCalgaryCanada
  5. 5.Li Ka Shing Knowledge Institute, St. Michael’s HospitalTorontoCanada
  6. 6.Deparment of Medicine and Clinical Epidemiology and BiostatisticsMcMaster UniversityHamiltonCanada
  7. 7.Department of Critical Care Medicine, Faculty of Medicine and Dentistry, and the School of Public HealthUniversity of AlbertaEdmontonCanada

Personalised recommendations